Researchers have developed lipid nanoparticles (LNPs) that cross the blood-brain barrier (BBB) and precisely target brain cells, a major step toward treating neurological diseases like Alzheimer’s.

Penn Engineers have modified lipid nanoparticles (LNPs) — the revolutionary technology behind the COVID-19 mRNA vaccines — to ...

The pensions minister rejected a call for the Government to reconsider its plans to means-test the winter fuel payment on ...

The DWP has urged those who do not receive Pension Credit and think they might be eligible to check. This can be done via the ...

The Jefferies target for 2025 on the Nifty 50 index, implies a potential upside of 10% from current levels. The Nifty has ...

As Australian baby boomers enter retirement, their finances are coming under further scrutiny - simply for having ...